Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v16-EN | Version v11-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2024-01-31 | 2023-10-19 |
| Drug Identification Number | 02231470 | 02231470 |
| Brand name | GAMMAGARD S/D | GAMMAGARD S/D |
| Common or Proper name | Immunoglobulin Intravenous (Human) | Immunoglobulin Intravenous (Human) |
| Company Name | TAKEDA CANADA INC | TAKEDA CANADA INC |
| Ingredients | IMMUNOGLOBULIN | IMMUNOGLOBULIN |
| Strength(s) | 5G | 5G |
| Dosage form(s) | KIT SOLUTION POWDER FOR SOLUTION | KIT SOLUTION POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 100 mL Vial | 100 mL Vial |
| ATC code | J06BA | J06BA |
| ATC description | IMMUNOGLOBULINS | IMMUNOGLOBULINS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2023-12-15 | 2023-12-15 |
| Actual start date | ||
| Estimated end date | 2024-04-30 | 2024-04-30 |
| Actual end date | 2024-01-29 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Shortage related to the disruption in supply of co-packaged sterile Water for Injection and not related to the immunoglobulin drug product. | Shortage related to the disruption in supply of co-packaged sterile Water for Injection and not related to the immunoglobulin drug product. |
| Health Canada comments |